Patent · US Active

Analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring

US9678105B2 · kind B2 · utility

0Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2014
Grant dateJun 13, 2017
Priority date
Expiry dateFeb 5, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/92
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Described herein is the analysis of nanomechanical characteristics of cells. In particular, changes in certain local nanomechanical characteristics of ex vivo human cells can correlate with presence of a human disease, such as cancer, as well as a particular stage of progression of the disease. Also, for human patients that are administered with a therapeutic agent, changes in local nanomechanical characteristics of ex vivo cells collected from the patients can correlate with effectiveness of the therapeutic agent in terms of impeding or reversing progression of the disease. By exploiting this correlation, systems and related methods can be advantageously implemented for disease state detection and therapeutic agent selection and monitoring.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.